Unaffected siblings of children with cystic fibrosis have a two in three chance of being carriers ofthe recessive gene. Depending on the genotype of the index case, it is often possible to determine the carrier status of these siblings. Although there is agreement that carrier testing should be offered to families of patients with cystic fibrosis, opinions vary as to whether this should be performed on children too young to be involved in the decision. The recent report from the Clinical Genetics Society (UK) was not in favour of testing children for recessive disorders that was of purely reproductive significance to that child in the future. 1 This study was designed to elicit the views of parents of children with cystic fibrosis over this issue. Most parents felt they had a right to know their child's carrier status within the context that two thirds thought that parents and child had equal rights to this knowledge. In contrast, 40% of geneticists said parents had no right at all and almost half the geneticists said the hospital need not automatically tell parents the results, even if requested. Furthermore, 60% would not inform parents if they knew the child to be a carrier after testing for the homozygous state. We feel it is wrong for the medical profession to withhold information of this nature from the family and no parent said they would withhold information from their child.
It is a fundamental right to have knowledge about one's own health and it ought to be an equal right to be able to refuse testing. This could pose a problem as 40% of the parents would go ahead with carrier testing even if the child did not wish to know his own status (although only one geneticist said they would agree to this). Good practice would make it prudent for children to be involved in any decision about testing their genotype, particularly when the test could be delayed until they are old enough to express an opinion. Some siblings might simply not want to know their carrier status and previous work has shown that not all relatives of a cystic fibrosis sufferer want to be tested.5
Conclusion
In conclusion, we have reported this study in order to stimulate further debate, particularly among clinicians looking after children with cystic fibrosis and their families. We have not said whether one side is right or wrong. It is unlikely that a consensus can be reached but each family must be taken on its own merit. As with many difficult ethical issues in clinical paediatrics, the problem still remains as to who should be making these sorts of decisions. Clearly it is important to involve all parties in the discussion and informed pretest counselling is obligatory. Although it may be prudent to wait until the child is old enough to make the decision, problems arise when parents of younger children are insistent. Determined parents will only go elsewhere to have the test done and it is likely that commercial pressures will eventually make genetic testing available both in private laboratories and from the local chemist (see a report in the Daily Express (8/8/94) entitled 'C25 DIY test to check for deadly genes'). Further discussion of these issues is now vital.
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